Recombinant Rat MFN2 Protein，His

MFN2 (Mitofusin 2) is a crucial protein that plays a pivotal role in the regulation of mitochondrial dynamics, particularly in the processes of mitochondrial fusion and overall cellular metabolism. Dysfunction in MFN2 has been associated with various neurodegenerative diseases, such as Charcot-Marie-Tooth disease type 2A, where mutations in the MFN2 gene lead to impaired mitochondrial function and neuronal degeneration. The protein is known to mediate the fusion of mitochondria, facilitating the exchange of mitochondrial contents and maintaining mitochondrial integrity, which is essential for energy production and apoptosis regulation. Recent research has highlighted the importance of MFN2 in maintaining cellular homeostasis and its potential as a therapeutic target for conditions characterized by mitochondrial dysfunction. Recombinant MFN2 protein studies contribute significantly to our understanding of mitochondrial biology, exploring its structure-function relationships and interactions with other mitochondrial proteins. By utilizing techniques such as X-ray crystallography and cryo-electron microscopy, researchers aim to elucidate the molecular mechanisms governing MFN2’s role in mitochondrial dynamics. Moreover, the development of recombinant MFN2 proteins provides a valuable tool for investigating its biochemical properties and functional implications in cellular models, offering insights into how restoring MFN2 function could ameliorate mitochondrial-related diseases. Given the central role of MFN2 in mitochondrial function, ongoing research focuses on its potential as a biomarker for disease progression and as a strategy for intervention in mitochondrial disorders. This research is crucial for advancing our understanding of mitochondrial biology and developing novel therapeutic approaches tailored to combat MFN2-related pathologies.